Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/2000
09/14/2000WO2000053733A2 Hermansky pudlak syndrome protein-interacting proteins and methods of use thereof
09/14/2000WO2000053730A2 Medical preparations for the treatment of alpha-galactosidase a deficiency
09/14/2000WO2000053634A1 Single-stranded fv inducing apoptosis
09/14/2000WO2000053633A2 Antibody and chemokine constructs that are directed to ccr5, and their use for treating autoimmune diseases
09/14/2000WO2000053632A1 Compounds and methods for stimulating gene expression and cellular differentiation
09/14/2000WO2000053631A1 Mammalian cytokines; related reagents and methods
09/14/2000WO2000053630A2 COMPOUNDS THAT DISRUPT MAMMALIAN Rad51 ACTIVITY
09/14/2000WO2000053629A1 Traf-3 deletion isoforms and uses thereof
09/14/2000WO2000053627A1 METHOD FOR PRODUCING CYCLO-(Asp-DPhe-NMeVal-Arg-Gly)
09/14/2000WO2000053626A1 Peptide having an antitumoral, protection and normalisation activity and pharmaceutical composition
09/14/2000WO2000053623A1 Bifunctional molecules for delivery of therapeutics
09/14/2000WO2000053621A2 Synthetic complementary peptides and ophthalmologic uses thereof
09/14/2000WO2000053605A1 Tyrosine kinase inhibitors
09/14/2000WO2000053602A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone
09/14/2000WO2000053583A1 Inhibitors of protein tyrosine phosphatase
09/14/2000WO2000053264A1 Treatment of thrombosis by combined use of a factor xa inhibitor and aspirin, tissue plasminogen activator (tpa), a gpiib/iiia antagonist, low molecular weight heparin or heparin
09/14/2000WO2000053236A2 Methods and compositions for targeted drug delivery
09/14/2000WO2000053233A1 Use of protein conformation for the protection and release of chemical compounds
09/14/2000WO2000053232A1 Matriptase, a serine protease and its applications
09/14/2000WO2000053227A1 Agents to increase the uptake of pharmaceuticals and diagnostic substances into solid tumors
09/14/2000WO2000053223A1 Apoptosis inducing molecule ii and methods of use
09/14/2000WO2000053219A2 Compositions and methods for treating cancer and hyperproliferative disorders
09/14/2000WO2000053218A1 Neurodegenerative disorder related gene
09/14/2000WO2000053217A2 Prevention of fetal alcohol syndrome and neuronal cell death with adnf polypeptides
09/14/2000WO2000053216A2 Use of casb616 polypeptides and polynucleotides for cancer treatment
09/14/2000WO2000053214A1 Use of interleukin-11 to prevent immune-mediated cytotoxicity
09/14/2000WO2000053213A2 Cyanovirin conjugates, matrix-anchored cyanovirin and anti-cyanovirin antibody, and related compositions and methods of use
09/14/2000WO2000053212A1 Pharmaceutical composition containing cyclosporin
09/14/2000WO2000053211A2 Method of promoting myocyte proliferation and myocardial tissue repair
09/14/2000WO2000053210A1 Methods of treatment and prevention of restenosis
09/14/2000WO2000053209A1 Treatment of autoimmune disease
09/14/2000WO2000053197A1 Matrix protein compositions for grafting
09/14/2000WO2000053196A1 Matrix protein compositions for induction of apoptosis
09/14/2000WO2000053189A1 Inhibitors of calcium influx factor synthesis and/or action and uses thereof
09/14/2000WO2000053178A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone
09/14/2000WO2000053172A1 Ccr-3 receptor antagonists
09/14/2000WO2000053168A2 Synergy between low molecular weight heparin and platelet aggregation inhibitors, for preventing and treating thromboembolic disorders
09/14/2000WO2000053167A2 Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
09/14/2000WO2000053148A2 Methods and compositions for treating erectile dysfunction
09/14/2000WO2000053019A1 Dna vaccination for treatment of autoimmune disease
09/14/2000WO2000053007A1 Organ transplant solutions containing conjugates of soluble peptidic compounds with membrane-binding
09/14/2000WO2000038737A3 GENE THERAPY FOR PULMONARY EDEMA USING ADENOVIRUS VECTORS ENCODING Na,K-ATPase
09/14/2000WO2000037685A3 Method of identifying a psychotropic agent using differential gene expression
09/14/2000WO2000037609A3 Orally immunogenic bacterial enterotoxins expressed in transgenic plants
09/14/2000WO2000037110A3 Ribavirin-pegylated interferon alfa induction hcv combination therapy
09/14/2000WO2000035469A3 hCG THERAPY FOR THE TREATMENT OF BREAST CANCER
09/14/2000WO2000035409A3 Hiv-i fusion inhibition compounds
09/14/2000WO2000034496A3 Use of trans-activation and cis-activation to modulate the persistence of expression of a transgene
09/14/2000WO2000031263A3 Gtpase associated proteins
09/14/2000WO2000031132A8 Novel polypeptide
09/14/2000WO2000030668A8 Use of parvovirus capsid particles in the inhibition of cell proliferation and migration
09/14/2000WO2000030587A3 NF-λB ACTIVATION INHIBITORS, AND THEIR PHARMACEUTICAL USES
09/14/2000WO2000030425A3 Method of using pon-1 to decrease atheroma formation
09/14/2000WO2000027883B1 A method of treating tumors using fas-induced apoptosis
09/14/2000WO2000027376A3 Use of thiol compounds, oxidoreductases and/or hydrolases for the treatment of tinnitus, especially chronic tinnitus
09/14/2000WO2000026395A3 Bovine cells expressing adenovirus essential functions for propagation of recombinant adenoviral vectors
09/14/2000WO2000024913A3 Mn gene and protein
09/14/2000WO2000024893A3 Methods and compositions for the prevention and treatment of anemia
09/14/2000WO2000024770A3 Dimeric thrombopoietin peptide mimetics binding to mp1 receptor and having thrombopoietic activity
09/14/2000WO2000023588B1 G-protein coupled receptors
09/14/2000WO2000022129A9 Non-endogenous, constitutively activated human g protein-coupled receptors
09/14/2000WO2000018232A9 Method of treatment of cardiovascular injuries
09/14/2000WO1999063999A8 H1-histamine receptor antagonists
09/14/2000WO1999062941A9 Serpentine transmembrane antigens expressed in human cancers and uses thereof
09/14/2000DE19911684A1 Human nucleic acid sequences from endothelial cells useful for treatment of angiogenic disease, including psoriasis, arthritis and diabetic retinopathy, etc
09/14/2000DE19911039A1 Abgewandelte Aminosäureamide, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung Modified amino acid amides, pharmaceutical compositions containing them and methods for their preparation
09/14/2000CA2833396A1 Treatment of alpha-galactosidase a deficiency
09/14/2000CA2367334A1 Compositions and methods for the treatment of tumors
09/14/2000CA2367315A1 Apoptosis inducing molecule ii and methods of use
09/14/2000CA2367144A1 Agents to increase the uptake of pharmaceuticals and diagnostic substances into solid tumors
09/14/2000CA2367113A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone
09/14/2000CA2367073A1 Organ transplant solutions containing conjugates of soluble peptidic compounds with membrane-binding
09/14/2000CA2366921A1 Novel cytokine zalpha11 ligand
09/14/2000CA2366713A1 Antibody and chemokine constructs and their use in the treatment of autoimmune diseases
09/14/2000CA2366706A1 Mammalian cytokines; related reagents and methods
09/14/2000CA2366689A1 Bifunctional molecules for delivery of therapeutics
09/14/2000CA2366678A1 Synthetic complementary peptides and ophthalmologic uses thereof
09/14/2000CA2366644A1 Tyrosine kinase inhibitors
09/14/2000CA2366615A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone
09/14/2000CA2366429A1 Methods and compositions for regulating memory consolidation
09/14/2000CA2366308A1 Inhibitors of protein tyrosine phosphatase
09/14/2000CA2366147A1 Casb618 polynucleotides and polypeptides and their use
09/14/2000CA2366124A1 Hermansky pudlak syndrome protein-interacting proteins and methods of use thereof
09/14/2000CA2366087A1 Sialic acid-binding ig-like lectin (siglec) gene; ob-binding protein like (ob-bpl)
09/14/2000CA2366058A1 Cdna molecules of the members of gene family encoding human fatty acid desaturases and their use in diagnosis and therapy
09/14/2000CA2365923A1 Medical preparations for the treatment of alpha-galactosidase a deficiency
09/14/2000CA2365354A1 Methods and compositions for targeted drug delivery
09/14/2000CA2364503A1 Compositions and methods for treating cancer and hyperproliferative disorders
09/14/2000CA2364500A1 Cyanovirin conjugates, matrix-anchored cyanovirin and anti-cyanovirin antibody, and related compositions and methods of use
09/14/2000CA2364487A1 Treatment of autoimmune disease
09/14/2000CA2364252A1 Synergy between low molecular weight heparin and platelet aggregation inhibitors, providing a combination therapy for the prevention and treatment of various thromboembolic disorders
09/14/2000CA2362918A1 Methods and compositions for treating erectile dysfunction
09/14/2000CA2362885A1 Human kallikrein-like genes
09/14/2000CA2362670A1 Matriptase, a serine protease and its applications
09/14/2000CA2362427A1 Compositions and methods for the treatment of immune related diseases
09/14/2000CA2362422A1 Polynucleotides and proteins encoded thereby
09/14/2000CA2362370A1 Use of casb616 polypeptides and polynucleotides for cancer treatment
09/14/2000CA2361849A1 Promotion or inhibition of angiogenesis and cardiovascularization
09/14/2000CA2361650A1 Treatment of thrombosis by combined use of a factor xa inhibitor and aspirin, tissue plasminogen activator (tpa), a gpiib/iiia antagonist, low molecular weight heparin or heparin
09/13/2000EP1035207A1 cDNA molecules of the members of gene family encoding human fatty acid desaturases and their use in diagnosis and therapy
1 ... 2347 2348 2349 2350 2351 2352 2353 2354 2355 2356 2357 2358 2359 2360 2361 2362 2363 2364 2365 2366 2367 ... 3163